Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	delayed rectifier potassium channel activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCNG1 KCNG4	3.44e-19	28	35	9	GO:0005251
GeneOntologyMolecularFunction	voltage-gated potassium channel activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.34e-17	102	35	11	GO:0005249
GeneOntologyMolecularFunction	potassium channel activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.77e-16	128	35	11	GO:0005267
GeneOntologyMolecularFunction	voltage-gated monoatomic cation channel activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.23e-15	152	35	11	GO:0022843
GeneOntologyMolecularFunction	potassium ion transmembrane transporter activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	3.52e-15	167	35	11	GO:0015079
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	9.18e-15	182	35	11	GO:0005244
GeneOntologyMolecularFunction	voltage-gated channel activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.04e-14	184	35	11	GO:0022832
GeneOntologyMolecularFunction	gated channel activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	7.10e-12	334	35	11	GO:0022836
GeneOntologyMolecularFunction	monoatomic cation channel activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	9.46e-12	343	35	11	GO:0005261
GeneOntologyMolecularFunction	monoatomic ion channel activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	2.13e-10	459	35	11	GO:0005216
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	2.45e-10	465	35	11	GO:0046873
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 KCNG1 KCNG4	3.57e-10	627	35	12	GO:0022890
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 KCNG1 KCNG4	6.86e-10	664	35	12	GO:0008324
GeneOntologyMolecularFunction	channel activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	8.81e-10	525	35	11	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	8.99e-10	526	35	11	GO:0022803
GeneOntologyMolecularFunction	outward rectifier potassium channel activity	KCNA2 KCNA3 KCNA5 KCND1 KCND3	9.64e-10	27	35	5	GO:0015271
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 KCNG1 KCNG4	3.07e-09	758	35	12	GO:0015318
GeneOntologyMolecularFunction	transmembrane transporter activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 SLC16A7 KCNG1 KCNG4 SLC16A14	4.22e-09	1180	35	14	GO:0022857
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 KCNG1 KCNG4	5.09e-09	793	35	12	GO:0015075
GeneOntologyMolecularFunction	transporter activity	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 SLC16A7 KCNG1 KCNG4 SLC16A14	1.31e-08	1289	35	14	GO:0005215
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	POTEE POTEI POTEF	8.06e-07	11	35	3	GO:0098973
GeneOntologyMolecularFunction	A-type (transient outward) potassium channel activity	KCND1 KCND3	1.79e-05	4	35	2	GO:0005250
GeneOntologyMolecularFunction	structural constituent of postsynapse	POTEE POTEI POTEF	2.36e-05	32	35	3	GO:0099186
GeneOntologyMolecularFunction	lactate transmembrane transporter activity	SLC16A1 SLC16A7	4.46e-05	6	35	2	GO:0015129
GeneOntologyMolecularFunction	structural constituent of synapse	POTEE POTEI POTEF	5.40e-05	42	35	3	GO:0098918
GeneOntologyMolecularFunction	voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	KCNA5 KCND3	3.09e-04	15	35	2	GO:0086008
GeneOntologyMolecularFunction	secondary active monocarboxylate transmembrane transporter activity	SLC16A1 SLC16A7	5.01e-04	19	35	2	GO:0015355
GeneOntologyMolecularFunction	monocarboxylic acid transmembrane transporter activity	SLC16A1 SLC16A7 SLC16A14	5.22e-04	90	35	3	GO:0008028
GeneOntologyMolecularFunction	fatty acid ligase activity	ACSL4 ACSS1	9.45e-04	26	35	2	GO:0015645
GeneOntologyMolecularFunction	translation regulator activity, nucleic acid binding	EEF2 EIF3F BOLL	9.86e-04	112	35	3	GO:0090079
GeneOntologyMolecularFunction	CoA-ligase activity	ACSL4 ACSS1	1.02e-03	27	35	2	GO:0016405
GeneOntologyMolecularFunction	acid-thiol ligase activity	ACSL4 ACSS1	1.34e-03	31	35	2	GO:0016878
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	POTEE POTEI POTEF	1.52e-03	130	35	3	GO:0005200
GeneOntologyMolecularFunction	symporter activity	SLC16A1 SLC16A7 SLC16A14	2.28e-03	150	35	3	GO:0015293
GeneOntologyMolecularFunction	ligase activity, forming carbon-sulfur bonds	ACSL4 ACSS1	2.34e-03	41	35	2	GO:0016877
GeneOntologyMolecularFunction	carboxylic acid transmembrane transporter activity	SLC16A1 SLC16A7 SLC16A14	5.63e-03	207	35	3	GO:0046943
GeneOntologyMolecularFunction	organic acid transmembrane transporter activity	SLC16A1 SLC16A7 SLC16A14	5.70e-03	208	35	3	GO:0005342
GeneOntologyMolecularFunction	organic hydroxy compound transmembrane transporter activity	SLC16A1 SLC16A7	6.69e-03	70	35	2	GO:1901618
GeneOntologyMolecularFunction	translation factor activity, RNA binding	EEF2 EIF3F	9.73e-03	85	35	2	GO:0008135
GeneOntologyMolecularFunction	scaffold protein binding	NLGN3 KCNA5	1.16e-02	93	35	2	GO:0097110
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	SLC16A1 SLC16A7 SLC16A14	1.45e-02	293	35	3	GO:0008514
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC16A1 SLC16A7 SLC16A14	1.49e-02	296	35	3	GO:0015291
GeneOntologyMolecularFunction	protein kinase binding	POTEE EEF2 POTEI KCNA5 POTEF	1.73e-02	873	35	5	GO:0019901
GeneOntologyBiologicalProcess	action potential	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.94e-14	201	35	11	GO:0001508
GeneOntologyBiologicalProcess	protein complex oligomerization	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 RRM2 KCND1 KCND3 KCNG1 KCNG4	3.80e-14	296	35	12	GO:0051259
GeneOntologyBiologicalProcess	protein homooligomerization	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	6.43e-14	224	35	11	GO:0051260
GeneOntologyBiologicalProcess	potassium ion transmembrane transport	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	9.46e-14	232	35	11	GO:0071805
GeneOntologyBiologicalProcess	potassium ion transport	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	5.40e-13	272	35	11	GO:0006813
GeneOntologyBiologicalProcess	regulation of membrane potential	NLGN3 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	6.60e-11	559	35	12	GO:0042391
GeneOntologyBiologicalProcess	monoatomic ion transmembrane transport	NLGN3 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 KCNG1 KCNG4	1.52e-08	1115	35	13	GO:0034220
GeneOntologyBiologicalProcess	inorganic cation transmembrane transport	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 KCNG1 KCNG4	1.91e-08	922	35	12	GO:0098662
GeneOntologyBiologicalProcess	monoatomic cation transmembrane transport	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 KCNG1 KCNG4	2.42e-08	942	35	12	GO:0098655
GeneOntologyBiologicalProcess	inorganic ion transmembrane transport	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 KCNG1 KCNG4	5.63e-08	1017	35	12	GO:0098660
GeneOntologyBiologicalProcess	monoatomic ion transport	NLGN3 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 KCNG1 KCNG4	1.78e-07	1374	35	13	GO:0006811
GeneOntologyBiologicalProcess	monoatomic cation transport	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 SLC16A1 KCND1 KCND3 KCNG1 KCNG4	2.30e-07	1157	35	12	GO:0006812
GeneOntologyBiologicalProcess	metal ion transport	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	4.70e-07	1000	35	11	GO:0030001
GeneOntologyBiologicalProcess	potassium ion export across plasma membrane	KCNA2 KCNA5 KCND3	5.83e-06	21	35	3	GO:0097623
GeneOntologyBiologicalProcess	postsynaptic actin cytoskeleton organization	POTEE POTEI POTEF	1.95e-05	31	35	3	GO:0098974
GeneOntologyBiologicalProcess	postsynaptic cytoskeleton organization	POTEE POTEI POTEF	2.82e-05	35	35	3	GO:0099188
GeneOntologyBiologicalProcess	plasma membrane lactate transport	SLC16A1 SLC16A7	4.18e-05	6	35	2	GO:0035879
GeneOntologyBiologicalProcess	pyruvate transmembrane transport	SLC16A1 SLC16A7	5.84e-05	7	35	2	GO:1901475
GeneOntologyBiologicalProcess	pyruvate transport	SLC16A1 SLC16A7	1.00e-04	9	35	2	GO:0006848
GeneOntologyBiologicalProcess	lactate transport	SLC16A1 SLC16A7	1.00e-04	9	35	2	GO:0015727
GeneOntologyBiologicalProcess	lactate transmembrane transport	SLC16A1 SLC16A7	1.00e-04	9	35	2	GO:0035873
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	SRF POTEE NLGN3 ARHGEF28 POTEI POTEF FAT3	2.22e-04	748	35	7	GO:0048667
GeneOntologyBiologicalProcess	axonogenesis	SRF POTEE NLGN3 ARHGEF28 POTEI POTEF	3.43e-04	566	35	6	GO:0007409
GeneOntologyBiologicalProcess	monocarboxylic acid transport	ACSL4 SLC16A1 SLC16A7 SLC16A14	4.50e-04	213	35	4	GO:0015718
GeneOntologyBiologicalProcess	export across plasma membrane	KCNA2 KCNA5 KCND3	4.91e-04	91	35	3	GO:0140115
GeneOntologyBiologicalProcess	optic nerve development	KCNA2 KCNA3	6.33e-04	22	35	2	GO:0021554
GeneOntologyBiologicalProcess	axon development	SRF POTEE NLGN3 ARHGEF28 POTEI POTEF	6.67e-04	642	35	6	GO:0061564
GeneOntologyBiologicalProcess	membrane repolarization during cardiac muscle cell action potential	KCNA5 KCND3	9.56e-04	27	35	2	GO:0086013
GeneOntologyBiologicalProcess	neuron projection development	SRF ACSL4 POTEE NLGN3 ARHGEF28 POTEI POTEF FAT3	1.15e-03	1285	35	8	GO:0031175
GeneOntologyBiologicalProcess	membrane repolarization during action potential	KCNA5 KCND3	1.26e-03	31	35	2	GO:0086011
GeneOntologyBiologicalProcess	cellular senescence	SRF ZNF217 MAP3K3	1.32e-03	128	35	3	GO:0090398
GeneOntologyBiologicalProcess	corpus callosum development	KCNA2 KCNA3	1.43e-03	33	35	2	GO:0022038
GeneOntologyBiologicalProcess	postsynapse organization	POTEE NLGN3 POTEI POTEF	1.88e-03	313	35	4	GO:0099173
GeneOntologyCellularComponent	voltage-gated potassium channel complex	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	2.18e-18	91	35	11	GO:0008076
GeneOntologyCellularComponent	potassium channel complex	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.01e-17	104	35	11	GO:0034705
GeneOntologyCellularComponent	cation channel complex	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	9.43e-14	235	35	11	GO:0034703
GeneOntologyCellularComponent	monoatomic ion channel complex	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.65e-11	378	35	11	GO:0034702
GeneOntologyCellularComponent	transmembrane transporter complex	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	5.25e-10	523	35	11	GO:1902495
GeneOntologyCellularComponent	transporter complex	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	8.92e-10	550	35	11	GO:1990351
GeneOntologyCellularComponent	plasma membrane protein complex	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	3.57e-08	785	35	11	GO:0098797
GeneOntologyCellularComponent	membrane protein complex	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	2.06e-05	1498	35	11	GO:0098796
GeneOntologyCellularComponent	H4/H2A histone acetyltransferase complex	POTEE POTEI POTEF	2.06e-05	32	35	3	GO:0043189
GeneOntologyCellularComponent	NuA4 histone acetyltransferase complex	POTEE POTEI POTEF	2.06e-05	32	35	3	GO:0035267
GeneOntologyCellularComponent	postsynaptic membrane	NLGN3 KCNA2 KCNA3 KCND1 KCND3 SLC16A7	5.14e-05	405	35	6	GO:0045211
GeneOntologyCellularComponent	H4 histone acetyltransferase complex	POTEE POTEI POTEF	5.81e-05	45	35	3	GO:1902562
GeneOntologyCellularComponent	synaptic membrane	NLGN3 KCNA2 KCNA3 KCND1 KCND3 SLC16A7	3.74e-04	583	35	6	GO:0097060
GeneOntologyCellularComponent	histone acetyltransferase complex	POTEE POTEI POTEF	5.19e-04	94	35	3	GO:0000123
GeneOntologyCellularComponent	protein acetyltransferase complex	POTEE POTEI POTEF	6.97e-04	104	35	3	GO:0031248
GeneOntologyCellularComponent	acetyltransferase complex	POTEE POTEI POTEF	7.99e-04	109	35	3	GO:1902493
GeneOntologyCellularComponent	calyx of Held	KCNA2 KCNA3	1.66e-03	36	35	2	GO:0044305
GeneOntologyCellularComponent	actin filament	POTEE POTEI POTEF	1.85e-03	146	35	3	GO:0005884
GeneOntologyCellularComponent	axon	POTEE KCNA2 KCNA3 POTEI KCNA6 POTEF	3.32e-03	891	35	6	GO:0030424
GeneOntologyCellularComponent	postsynaptic specialization membrane	NLGN3 KCND3 SLC16A7	4.57e-03	201	35	3	GO:0099634
GeneOntologyCellularComponent	axon terminus	KCNA2 KCNA3 KCNA6	5.16e-03	210	35	3	GO:0043679
GeneOntologyCellularComponent	postsynapse	NLGN3 KCNA2 KCNA3 KCND1 KCND3 SLC16A7	6.35e-03	1018	35	6	GO:0098794
GeneOntologyCellularComponent	neuron projection terminus	KCNA2 KCNA3 KCNA6	6.88e-03	233	35	3	GO:0044306
MousePheno	increased growth rate	NLGN3 ARHGEF28 ACSS1	3.22e-06	15	28	3	MP:0002865
Domain	K_chnl_volt-dep_Kv	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.52e-24	27	34	11	IPR003968
Domain	VG_K_chnl	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	2.24e-23	33	34	11	IPR028325
Domain	BTB_2	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	8.63e-21	53	34	11	PF02214
Domain	T1-type_BTB	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	8.63e-21	53	34	11	IPR003131
Domain	Channel_four-helix_dom	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	2.08e-20	57	34	11	IPR027359
Domain	-	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	2.08e-20	57	34	11	1.20.120.350
Domain	Ion_trans_dom	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	6.80e-17	114	34	11	IPR005821
Domain	Ion_trans	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	6.80e-17	114	34	11	PF00520
Domain	K_chnl_volt-dep_Kv1	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10	6.38e-16	8	34	6	IPR003972
Domain	BTB	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.16e-14	180	34	11	SM00225
Domain	BTB/POZ_dom	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.57e-14	185	34	11	IPR000210
Domain	SKP1/BTB/POZ	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.99e-14	189	34	11	IPR011333
Domain	Actin_CS	POTEE POTEI POTEF	3.04e-06	16	34	3	IPR004001
Domain	ACTINS_2	POTEE POTEI POTEF	3.68e-06	17	34	3	PS00432
Domain	Actin/actin-like_CS	POTEE POTEI POTEF	4.41e-06	18	34	3	IPR020902
Domain	ACTINS_ACT_LIKE	POTEE POTEI POTEF	5.24e-06	19	34	3	PS01132
Domain	DUF3399	KCND1 KCND3	9.64e-06	3	34	2	PF11879
Domain	K_chnl_volt-dep_Kv4	KCND1 KCND3	9.64e-06	3	34	2	IPR003975
Domain	Shal-type	KCND1 KCND3	9.64e-06	3	34	2	PF11601
Domain	K_chnl_volt-dep_Kv6	KCNG1 KCNG4	9.64e-06	3	34	2	IPR003969
Domain	Shal-type_N	KCND1 KCND3	9.64e-06	3	34	2	IPR021645
Domain	K_chnl_volt-dep_Kv4_C	KCND1 KCND3	9.64e-06	3	34	2	IPR024587
Domain	Actin	POTEE POTEI POTEF	2.39e-05	31	34	3	IPR004000
Domain	Actin	POTEE POTEI POTEF	2.39e-05	31	34	3	PF00022
Domain	ACTIN	POTEE POTEI POTEF	2.39e-05	31	34	3	SM00268
Domain	MCT	SLC16A1 SLC16A7	3.21e-05	5	34	2	IPR004743
Domain	K_chnl_volt-dep_Kv9	KCNG3 KCNG4	6.72e-05	7	34	2	IPR003971
Domain	MFS	SLC16A1 SLC16A7 SLC16A14	3.68e-04	77	34	3	IPR011701
Domain	MFS_1	SLC16A1 SLC16A7 SLC16A14	3.68e-04	77	34	3	PF07690
Domain	MFS	SLC16A1 SLC16A7 SLC16A14	9.88e-04	108	34	3	PS50850
Domain	AMP-binding_CS	ACSL4 ACSS1	1.02e-03	26	34	2	IPR020845
Domain	ANK_REPEAT	MUC16 POTEE POTEI POTEF	1.11e-03	253	34	4	PS50088
Domain	ANK_REP_REGION	MUC16 POTEE POTEI POTEF	1.12e-03	254	34	4	PS50297
Domain	AMP_BINDING	ACSL4 ACSS1	1.18e-03	28	34	2	PS00455
Domain	AMP-binding	ACSL4 ACSS1	1.36e-03	30	34	2	PF00501
Domain	AMP-dep_Synth/Lig	ACSL4 ACSS1	1.36e-03	30	34	2	IPR000873
Domain	MFS_dom	SLC16A1 SLC16A7 SLC16A14	1.84e-03	134	34	3	IPR020846
Domain	Ank_2	POTEE POTEI POTEF	6.92e-03	215	34	3	PF12796
Domain	Ank	POTEE POTEI POTEF	8.13e-03	228	34	3	PF00023
Domain	-	POTEE POTEI POTEF	1.02e-02	248	34	3	1.25.40.20
Domain	ANK	POTEE POTEI POTEF	1.06e-02	251	34	3	SM00248
Domain	Ankyrin_rpt-contain_dom	POTEE POTEI POTEF	1.09e-02	254	34	3	IPR020683
Domain	Ankyrin_rpt	POTEE POTEI POTEF	1.18e-02	262	34	3	IPR002110
Pathway	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	9.68e-22	41	29	11	MM14546
Pathway	REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.76e-21	43	29	11	M1056
Pathway	REACTOME_POTASSIUM_CHANNELS	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	3.21e-17	98	29	11	MM14545
Pathway	REACTOME_POTASSIUM_CHANNELS	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	5.68e-17	103	29	11	M1073
Pathway	REACTOME_NEURONAL_SYSTEM	NLGN3 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	9.63e-13	335	29	12	MM14503
Pathway	REACTOME_NEURONAL_SYSTEM	NLGN3 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.07e-11	411	29	12	M735
Pathway	REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT	SLC16A1 SLC16A7	6.10e-05	6	29	2	MM17217
Pathway	REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT	SLC16A1 SLC16A7	6.10e-05	6	29	2	M27355
Pathway	REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS	KCND1 KCND3	8.53e-05	7	29	2	M27457
Pathway	REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS	KCND1 KCND3	8.53e-05	7	29	2	MM15199
Pathway	WP_ADHD_AND_AUTISM_ASD_PATHWAYS	NLGN3 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7	8.55e-05	367	29	6	M48346
Pathway	BIOCARTA_BARRESTIN_PATHWAY	KCNA2 KCNA3	2.22e-04	11	29	2	MM1501
Pathway	BIOCARTA_BARRESTIN_PATHWAY	KCNA2 KCNA3	2.66e-04	12	29	2	M7772
Pathway	WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS	SLC16A1 SLC16A7	3.14e-04	13	29	2	M48056
Pathway	BIOCARTA_BARR_MAPK_PATHWAY	KCNA2 KCNA3	3.66e-04	14	29	2	M668
Pathway	BIOCARTA_BARR_MAPK_PATHWAY	KCNA2 KCNA3	3.66e-04	14	29	2	MM1489
Pathway	WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL	KCNA2 SLC16A1 SLC16A7	4.42e-04	73	29	3	MM16641
Pathway	BIOCARTA_BARRESTIN_SRC_PATHWAY	KCNA2 KCNA3	5.45e-04	17	29	2	M111
Pathway	BIOCARTA_BARRESTIN_SRC_PATHWAY	KCNA2 KCNA3	5.45e-04	17	29	2	MM1491
Pathway	REACTOME_CARDIAC_CONDUCTION	KCNA5 KCND1 KCND3	1.21e-03	103	29	3	MM15196
Pathway	REACTOME_CARDIAC_CONDUCTION	KCNA5 KCND1 KCND3	2.35e-03	130	29	3	M27454
Pubmed	International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels.	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	4.20e-25	40	35	11	16382104
Pubmed	Voltage-gated potassium channel genes are clustered in paralogous regions of the mouse genome.	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCND1	1.42e-15	31	35	7	8034307
Pubmed	Physical mapping of potassium channel gene clusters on mouse chromosomes three and six.	KCNA2 KCNA3 KCNA5 KCNA6 KCNA10	4.59e-15	6	35	5	9286706
Pubmed	Developmental expression of voltage-sensitive K+ channels in mouse skeletal muscle and C2C12 cells.	KCNA2 KCNA3 KCNA5 KCNA6 KCND1	1.92e-13	10	35	5	1383027
Pubmed	Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development.	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCND1 KCND3	8.56e-11	139	35	7	16985003
Pubmed	Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7.	KCNA2 KCNA3 KCNA6 KCNA7	1.08e-10	9	35	4	9488722
Pubmed	Mutation of histidine 105 in the T1 domain of the potassium channel Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4.	KCNG3 KCNG1 KCNG4	9.32e-09	5	35	3	19074135
Pubmed	Contribution of Kv1.2 voltage-gated potassium channel to D2 autoreceptor regulation of axonal dopamine overflow.	KCNA2 KCNA3 KCNA6	9.32e-09	5	35	3	21233214
Pubmed	Chromosomal mapping in the mouse of eight K(+)-channel genes representing the four Shaker-like subfamilies Shaker, Shab, Shaw, and Shal.	KCNA2 KCNA3 KCNA5 KCNA6	1.26e-08	26	35	4	7905852
Pubmed	Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly.	KCNA2 KCNA3 KCNA6	1.86e-08	6	35	3	14686897
Pubmed	Pore size matters for potassium channel conductance.	KCNA2 KCNA6 KCNA10	3.26e-08	7	35	3	27619418
Pubmed	N-terminal PDZ-binding domain in Kv1 potassium channels.	KCNA2 KCNA3 KCNA5	5.21e-08	8	35	3	12435606
Pubmed	Ion channel expression in the developing enteric nervous system.	KCNA2 KCNA5 KCNA6 KCND3	5.54e-08	37	35	4	25798587
Pubmed	The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.	SLC16A1 SLC16A7 SLC16A14	3.37e-07	14	35	3	12739169
Pubmed	Identification of a novel actin isoform in hepatocellular carcinoma.	POTEE POTEI POTEF	4.21e-07	15	35	3	16824795
Pubmed	Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein.	KCNA3 KCND1 KCND3	4.21e-07	15	35	3	10479680
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	ACSL4 KCNA2 KCNA3 KCNA5 KCNG3 KCNA10 KCND3 KCNG1	5.17e-07	730	35	8	34857952
Pubmed	Alteration of Neuronal Excitability and Short-Term Synaptic Plasticity in the Prefrontal Cortex of a Mouse Model of Mental Illness.	KCNA2 KCNA3 KCNA6	5.18e-07	16	35	3	28283561
Pubmed	The Vertebrate Genome Annotation browser 10 years on.	POTEE STOX2 KCNA2 POTEI POTEF	6.16e-07	163	35	5	24316575
Pubmed	Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages.	KCNA3 KCNA5	9.84e-07	2	35	2	17038323
Pubmed	Presence and localization of three lactic acid transporters (MCT1, -2, and -4) in separated human granulocytes, lymphocytes, and monocytes.	SLC16A1 SLC16A7	9.84e-07	2	35	2	15505343
Pubmed	Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system.	KCNA3 KCNA5	9.84e-07	2	35	2	16729292
Pubmed	Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages.	KCNA3 KCNA5	9.84e-07	2	35	2	17157812
Pubmed	Myocardin-Dependent Kv1.5 Channel Expression Prevents Phenotypic Modulation of Human Vessels in Organ Culture.	KCNA3 KCNA5	9.84e-07	2	35	2	31597447
Pubmed	Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis.	SLC16A1 SLC16A7	9.84e-07	2	35	2	36814318
Pubmed	Monocarboxylate transporter expression in mouse brain.	SLC16A1 SLC16A7	9.84e-07	2	35	2	9725820
Pubmed	Expression and chromosomal localization of a lymphocyte K+ channel gene.	KCNA2 KCNA3	9.84e-07	2	35	2	2251283
Pubmed	Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer.	SLC16A1 SLC16A7	9.84e-07	2	35	2	25492048
Pubmed	Cell-specific expression pattern of monocarboxylate transporters in astrocytes and neurons observed in different mouse brain cortical cell cultures.	SLC16A1 SLC16A7	9.84e-07	2	35	2	12836157
Pubmed	Estrogen contributes to gender differences in mouse ventricular repolarization.	KCNA5 KCND3	9.84e-07	2	35	2	19608983
Pubmed	Inter-Regulation of Kv4.3 and Voltage-Gated Sodium Channels Underlies Predisposition to Cardiac and Neuronal Channelopathies.	KCNA5 KCND3	9.84e-07	2	35	2	32709127
Pubmed	Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels.	KCNA2 KCNA5	9.84e-07	2	35	2	12815189
Pubmed	A primate-specific POTE-actin fusion protein plays a role in apoptosis.	POTEE POTEF	9.84e-07	2	35	2	19669888
Pubmed	Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain.	SLC16A1 SLC16A7	9.84e-07	2	35	2	9520480
Pubmed	Differential expression of Kv1.3 and Kv1.5 voltage-dependent K+ channels in human skeletal muscle sarcomas.	KCNA3 KCNA5	9.84e-07	2	35	2	22360360
Pubmed	Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas.	KCNA3 KCNA5	9.84e-07	2	35	2	12850541
Pubmed	Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human fetus.	KCNA3 KCNA5	9.84e-07	2	35	2	20798505
Pubmed	Isoenzyme-specific regulation of cardiac Kv1.5/Kvβ1.2 ion channel complex by protein kinase C: central role of PKCβII.	KCNA2 KCNA5	2.95e-06	3	35	2	24682423
Pubmed	Unique clustering of A-type potassium channels on different cell types of the main olfactory bulb.	KCND1 KCND3	2.95e-06	3	35	2	18371079
Pubmed	Sequence and functional expression in Xenopus oocytes of a human insulinoma and islet potassium channel.	KCNA3 KCNA5	2.95e-06	3	35	2	1986382
Pubmed	Caveolin interaction governs Kv1.3 lipid raft targeting.	KCNA3 KCNA5	2.95e-06	3	35	2	26931497
Pubmed	Cloning, sequence and chromosomal localization of MK6, a murine potassium channel gene.	KCNA2 KCNA6	2.95e-06	3	35	2	1285906
Pubmed	Evolution and expression of chimeric POTE-actin genes in the human genome.	POTEE POTEF	2.95e-06	3	35	2	17101985
Pubmed	Clinical spectrum of voltage-gated potassium channel autoimmunity.	KCNA2 KCNA6	2.95e-06	3	35	2	18474843
Pubmed	Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons.	KCNA2 KCNA6	2.95e-06	3	35	2	17634333
Pubmed	Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas.	SLC16A1 SLC16A7	2.95e-06	3	35	2	18188595
Pubmed	Characterization of a voltage-activated K-channel gene cluster on human chromosome 12p13.	KCNA5 KCNA6	2.95e-06	3	35	2	8821794
Pubmed	Basigin interacts with both MCT1 and MCT2 in murine spermatozoa.	SLC16A1 SLC16A7	2.95e-06	3	35	2	21792931
Pubmed	Potassium Channels Kv1.3 and Kir2.1 But Not Kv1.5 Contribute to BV2 Cell Line and Primary Microglial Migration.	KCNA3 KCNA5	2.95e-06	3	35	2	33669857
Pubmed	Cellular expression of a sodium-dependent monocarboxylate transporter (Slc5a8) and the MCT family in the mouse kidney.	SLC16A1 SLC16A7	2.95e-06	3	35	2	18751721
Pubmed	Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes.	SLC16A1 SLC16A7	2.95e-06	3	35	2	19876643
Pubmed	Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer.	SLC16A1 SLC16A7	2.95e-06	3	35	2	25578492
Pubmed	Identification of the essential extracellular aspartic acids conserved in human monocarboxylate transporters 1, 2, and 4.	SLC16A1 SLC16A7	2.95e-06	3	35	2	32819565
Pubmed	Gene structures and expression profiles of three human KCND (Kv4) potassium channels mediating A-type currents I(TO) and I(SA).	KCND1 KCND3	2.95e-06	3	35	2	10729221
Pubmed	A family of three mouse potassium channel genes with intronless coding regions.	KCNA2 KCNA3	2.95e-06	3	35	2	2305265
Pubmed	Kv2.1 and electrically silent Kv6.1 potassium channel subunits combine and express a novel current.	KCNA2 KCNG1	2.95e-06	3	35	2	8980147
Pubmed	Enhanced expression of three monocarboxylate transporter isoforms in the brain of obese mice.	SLC16A1 SLC16A7	2.95e-06	3	35	2	17599960
Pubmed	Kv1.5 association modifies Kv1.3 traffic and membrane localization.	KCNA3 KCNA5	5.90e-06	4	35	2	18218624
Pubmed	KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels.	KCNA2 KCNA3	5.90e-06	4	35	2	12944270
Pubmed	Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.	KCNA3 KCNA5	5.90e-06	4	35	2	24249731
Pubmed	Notch enhances Ca2+ entry by activating calcium-sensing receptors and inhibiting voltage-gated K+ channels.	KCNA2 KCNA5	5.90e-06	4	35	2	32186932
Pubmed	Monocarboxylate transport in human corneal epithelium and cell lines.	SLC16A1 SLC16A7	5.90e-06	4	35	2	20035863
Pubmed	K+ current diversity is produced by an extended gene family conserved in Drosophila and mouse.	KCNA2 KCNA3	9.82e-06	5	35	2	2333511
Pubmed	Cysteine 159 delineates a hinge region of the alternating access monocarboxylate transporter 1 and is targeted by cysteine-modifying inhibitors.	SLC16A1 SLC16A7	9.82e-06	5	35	2	33999492
Pubmed	A mechanism for combinatorial regulation of electrical activity: Potassium channel subunits capable of functioning as Src homology 3-dependent adaptors.	KCNA2 KCNA5	9.82e-06	5	35	2	11149959
Pubmed	Astrocytic metabolic control of orexinergic activity in the lateral hypothalamus regulates sleep and wake architecture.	SLC16A1 SLC16A7	9.82e-06	5	35	2	39013907
Pubmed	Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44.	SLC16A1 SLC16A7	9.82e-06	5	35	2	20454640
Pubmed	Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.	SLC16A1 SLC16A7	9.82e-06	5	35	2	21787388
Pubmed	The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient.	KCNA5 KCND3	9.82e-06	5	35	2	16239150
Pubmed	Subunit composition of Kv1 channels in human CNS.	KCNA2 KCNA3	9.82e-06	5	35	2	10428084
Pubmed	Genetic expression of monocarboxylate transporters during human and murine oocyte maturation and early embryonic development.	SLC16A1 SLC16A7	9.82e-06	5	35	2	12056458
Pubmed	Protein kinase C (PKC) activity regulates functional effects of Kvβ1.3 subunit on KV1.5 channels: identification of a cardiac Kv1.5 channelosome.	KCNA3 KCNA5	1.47e-05	6	35	2	22547057
Pubmed	Molecular genetic analysis of distal mouse chromosome 6 defines gene order and positions of the deafwaddler and opisthotonos mutations.	KCNA5 KCNA6	1.47e-05	6	35	2	8530061
Pubmed	Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70).	SLC16A1 SLC16A7	1.47e-05	6	35	2	15917240
Pubmed	Differential K+ channel clustering activity of PSD-95 and SAP97, two related membrane-associated putative guanylate kinases.	KCNA2 KCNA3	1.47e-05	6	35	2	8938729
Pubmed	Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f).	KCNA5 KCND3	1.47e-05	6	35	2	18603586
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	STOX2 ARHGEF28 KCNA7 RRM2 SLC16A1 POTEF MAP3K3	2.04e-05	861	35	7	36931259
Pubmed	Obligatory heterotetramerization of three previously uncharacterized Kv channel alpha-subunits identified in the human genome.	KCNG3 KCNG4	2.06e-05	7	35	2	12060745
Pubmed	Localization of members of MCT monocarboxylate transporter family Slc16 in the kidney and regulation during metabolic acidosis.	SLC16A1 SLC16A7	2.06e-05	7	35	2	20392797
Pubmed	Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases.	KCNA2 KCNA3	2.06e-05	7	35	2	7477295
Pubmed	Heteromultimeric delayed-rectifier K+ channels in schwann cells: developmental expression and role in cell proliferation.	KCNA2 KCNA5	2.06e-05	7	35	2	9852577
Pubmed	Cited2 is required in trophoblasts for correct placental capillary patterning.	SLC16A1 SLC16A7	2.74e-05	8	35	2	24803182
Pubmed	Distribution of monocarboxylate transporters in the peripheral nervous system suggests putative roles in lactate shuttling and myelination.	SLC16A1 SLC16A7	2.74e-05	8	35	2	25762662
Pubmed	KCNE2 forms potassium channels with KCNA3 and KCNQ1 in the choroid plexus epithelium.	KCNA3 KCNA6	2.74e-05	8	35	2	21859894
Pubmed	Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains.	POTEE POTEI	3.53e-05	9	35	2	16364570
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	STOX2 KCNA2 KCNA3 KCNA6	4.56e-05	197	35	4	36604605
Pubmed	The glucose-lactic acid cycle and gluconeogenesis.	SLC16A1 SLC16A7	6.45e-05	12	35	2	7273846
Pubmed	Mediator requirement for both recruitment and postrecruitment steps in transcription initiation.	SRF EEF2	6.45e-05	12	35	2	15749018
Pubmed	Functional suppression of Kcnq1 leads to early sodium channel remodelling and cardiac conduction system dysmorphogenesis.	KCNA5 KCND3	8.89e-05	14	35	2	23542581
Pubmed	SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243.	POTEE EIF3F POTEF	1.21e-04	95	35	3	33863777
Pubmed	Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy.	POTEE POTEI POTEF	1.25e-04	96	35	3	23580065
Pubmed	Synergistic gene interactions control the induction of the mitochondrial uncoupling protein (Ucp1) gene in white fat tissue.	KCNA2 KCNA10	1.33e-04	17	35	2	10931824
Pubmed	The interaction between ubiquitin C-terminal hydrolase 37 and glucose-regulated protein 78 in hepatocellular carcinoma.	POTEE EEF2 POTEF	1.41e-04	100	35	3	21800051
Pubmed	CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.	POTEE EEF2 POTEI POTEF	1.97e-04	288	35	4	31501420
Pubmed	Interaction proteomics of canonical Caspr2 (CNTNAP2) reveals the presence of two Caspr2 isoforms with overlapping interactomes.	KCNA2 KCNA6	2.04e-04	21	35	2	25707359
Pubmed	LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.	ACSL4 POTEE EEF2 EIF3F POTEF	2.72e-04	580	35	5	35676659
Pubmed	TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer.	ACSL4 EEF2	4.20e-04	30	35	2	34285210
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	ACSL4 EEF2 EIF3F RRM2 SLC16A1	4.49e-04	647	35	5	26618866
Pubmed	Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.	POTEE POTEI POTEF	4.56e-04	149	35	3	22664934
Pubmed	Splicing Regulator p54nrb /Non-POU Domain-Containing Octamer-Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box-Dependent Interacting Protein 1 in Hepatocellular Carcinoma.	POTEE EEF2	4.79e-04	32	35	2	31815296
Interaction	DOLK interactions	KCNA2 KCNA3 KCNA5 KCNA6 KCNA10	3.29e-08	55	34	5	int:DOLK
Interaction	KCNA2 interactions	KCNA2 KCNA3 KCNA5 KCNA10 KCND3 KCNG1	5.89e-08	125	34	6	int:KCNA2
Interaction	KCNAB2 interactions	KCNA2 KCNA3 KCNA5 KCNA6 KCNA10	6.07e-08	62	34	5	int:KCNAB2
Interaction	KCNB1 interactions	KCNA2 KCNG3 KCNG1 KCNG4	7.95e-07	43	34	4	int:KCNB1
Interaction	KCNA5 interactions	KCNA2 KCNA3 KCNA5 KCND3	3.08e-06	60	34	4	int:KCNA5
Interaction	KCNA1 interactions	KCNA2 KCNA3 KCNA10	2.77e-05	35	34	3	int:KCNA1
Interaction	HSP90AA1 interactions	EEF2 EIF3F KCNA3 KCNA5 KCNA6 RRM2 KCND3 KCNG1 SPSB3 MAP3K3	2.95e-05	1263	34	10	int:HSP90AA1
Interaction	KCND3 interactions	KCNA2 KCNA5 KCND3	7.67e-05	49	34	3	int:KCND3
Interaction	ACTG2 interactions	POTEE POTEI POTEF	7.67e-05	49	34	3	int:ACTG2
Interaction	DLG4 interactions	NLGN3 STOX2 KCNA2 KCNA3 KCNA5 KCNA6	9.37e-05	449	34	6	int:DLG4
Interaction	GOLM1 interactions	KCNA2 KCNA5 KCNA6 KCNA10	1.01e-04	145	34	4	int:GOLM1
Interaction	ATPSCKMT interactions	POTEI POTEF	1.51e-04	11	34	2	int:ATPSCKMT
Interaction	KCNB2 interactions	KCNG3 KCNG1 KCNG4	1.87e-04	66	34	3	int:KCNB2
Interaction	DEGS1 interactions	POTEE KCNA2 SLC16A1	1.95e-04	67	34	3	int:DEGS1
Interaction	KCNA4 interactions	KCNA2 KCNA3 KCNA5	2.04e-04	68	34	3	int:KCNA4
Cytoband	Ensembl 112 genes in cytogenetic band chr1p13	KCNA2 KCNA3 KCNA10 SLC16A1 KCND3	5.67e-07	211	35	5	chr1p13
Cytoband	2q21.1	POTEE POTEI POTEF	1.22e-05	58	35	3	2q21.1
Cytoband	Ensembl 112 genes in cytogenetic band chr2q21	POTEE POTEI POTEF	2.11e-04	151	35	3	chr2q21
Cytoband	12p13	KCNA5 KCNA6	1.10e-03	64	35	2	12p13
Cytoband	1p13.3	KCNA3 KCND3	1.28e-03	69	35	2	1p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chrXq23	ACSL4 RTL9	2.12e-03	89	35	2	chrXq23
GeneFamily	Potassium voltage-gated channels	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	2.87e-23	40	28	11	274
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEE POTEI POTEF	9.42e-07	13	28	3	685
GeneFamily	Acyl-CoA synthetase family	ACSL4 ACSS1	7.35e-04	26	28	2	40
GeneFamily	Ankyrin repeat domain containing	POTEE POTEI POTEF	6.06e-03	242	28	3	403
GeneFamily	Solute carriers	SLC16A1 SLC16A7 SLC16A14	2.26e-02	395	28	3	752
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KCNA2 KCNA3 KCNA5 KCND3	6.36e-06	154	35	4	44d4d99b08216c0901e3bc32743fa0a8b85b5149
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA5 KCNA6	1.05e-05	175	35	4	c1e082538f31b5c98ac63f71dcca4a1211a14708
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA5 KCNA6	1.05e-05	175	35	4	c36b4526970db9ccfbe2c70b00961fab9f13b133
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA5 KCNA6	1.05e-05	175	35	4	2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce
ToppCell	TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11\|TCGA-Brain / Sample_Type by Project: Shred V9	POTEE POTEI POTEF	1.66e-05	63	35	3	d7dc1356a60cb527fe668328d5375f352239d911
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9\|TCGA-Breast / Sample_Type by Project: Shred V9	POTEE POTEI POTEF	4.84e-05	90	35	3	96e836c7a1df279ac812b7c3aa75e6b81b614244
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast-Proliferative_Immature_MyoFibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	KCNA5 KCNA6 KCNA7	1.61e-04	135	35	3	ed0f94d3839eea3b60217c4352159ed481361f13
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SRF RRM2 KCND1	1.76e-04	139	35	3	505bf5a483fc2ba69377db9850c3b26ab2f416d1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NLGN3 KCNA2 KCND3	2.07e-04	147	35	3	5e6dd2ddc67b3722f6528e7277cbc7f296098687
ToppCell	PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	MUC16 SLC16A1 KCND3	2.47e-04	156	35	3	605d95a900e1443d3f6aae163ef2e893d3293203
ToppCell	PND07-28-samps-Mesenchymal-Mesothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	MUC16 SLC16A1 KCND3	2.47e-04	156	35	3	574f761962a7dd3308bd41fc529dd3ea1b8625f8
ToppCell	Bac-SEP-Lymphocyte-T_NK-dnT\|Bac-SEP / Disease, Lineage and Cell Type	KCNA3 SLC16A14 ACSS1	2.66e-04	160	35	3	f5ca49801c981b903a85a64b21ece6b59fe91cbc
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACSL4 KCNA7 ACSS1	2.76e-04	162	35	3	8e0f03fcc25b2ea777e8478fbf771699cf93719c
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACSL4 KCNA7 ACSS1	2.76e-04	162	35	3	e0417f1242edf71934fe62bccc55c4678f7ff4ac
ToppCell	COVID-CD8-exh_CD4\|COVID / Condition, Cell_class and T cell subcluster	KCNA2 SLC16A1 SLC16A7	2.96e-04	166	35	3	4ca8c91b03d08489f244898cf9423b9d10348bc8
ToppCell	droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNA3 KCND3 ACSS1	3.12e-04	169	35	3	c5015ddb838849ea892a2cae5a739b554eb6d793
ToppCell	P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NLGN3 KCNA2 KCNA6	3.28e-04	172	35	3	8d6a2a0d5f63b09a5a304a77e600a647f87e9de4
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MUC16 SLC16A1 SLC16A14	3.34e-04	173	35	3	3725525b99a6011eda2ff5459b4fd2e1eab1f090
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MUC16 SLC16A1 SLC16A14	3.34e-04	173	35	3	ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Endothelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNA2 KCNA5 KCNG3	3.40e-04	174	35	3	fa6eb451555766398996bbe8f555a3f4c0f3c108
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNA2 KCNA5 KCNG3	3.40e-04	174	35	3	1f5b0fa58b2a7335667357af7e50e5242cd13d7d
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNA2 KCNA5 KCNG3	3.40e-04	174	35	3	ac3aee6ed49d1c421f33509e3ffc5cb17750a473
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 RRM2 KCND1	3.40e-04	174	35	3	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	pdx-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ARHGEF28 KCND3 POTEF	3.51e-04	176	35	3	1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	STOX2 ARHGEF28 OR13C4	3.63e-04	178	35	3	544379f5a6145429762258d426b876bb36c112f5
ToppCell	droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA6	3.63e-04	178	35	3	3e8aacb27ed1a3c3978e21dddddd0828f8000692
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNA6 SLC16A1 FAT3	3.69e-04	179	35	3	c7c74e26bbf86c5326ee38bac7de111d5414f46b
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	POTEE POTEI POTEF	3.75e-04	180	35	3	beb4d777e0c5fa0a59672dbc3dbb7732498605ff
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	POTEE POTEI POTEF	3.75e-04	180	35	3	fb3d549c2a69b2157a486786ddd775ca16699ed0
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA6	3.87e-04	182	35	3	d568a8aec7e27ce632e248baea2ccd0e8dd255ac
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA6	3.87e-04	182	35	3	e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSL4 SLC16A7 ACSS1	3.87e-04	182	35	3	ccfee33de0faebbe69099d4ff3c3971f6a708b99
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA6	3.87e-04	182	35	3	82ca6d5ed48b4c487ce00b9309255abb8f20b61d
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA6	3.94e-04	183	35	3	2cf36ad89584eb9f8b04de52a1b511b7f3527884
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA6	3.94e-04	183	35	3	98fee6838acfaee5e2e449ba088764ec06b8bc57
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EEF2 KCNG3 SLC16A7	4.06e-04	185	35	3	9438097e94219c1db922b8507e3a29106d32a923
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRF EEF2 EIF3F	4.13e-04	186	35	3	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	Anterior_Cingulate_gyrus_(CgG)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNA3 ARHGEF28 KCNG1	4.13e-04	186	35	3	32af3f211f9ad5d5c6b86b83325cfbf2f8466b56
ToppCell	Healthy-multiplets\|Healthy / disease group, cell group and cell class	RRM2 KCND3 SLC16A14	4.13e-04	186	35	3	2ec999b97e95afb898f8083042b0f188d3d234bc
ToppCell	droplet-Heart-HEART-1m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA6	4.13e-04	186	35	3	fddc6b93f98b10aaf8d4ebc142b46d8213f3129d
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STOX2 KCNA2 KCNA6	4.19e-04	187	35	3	8e8b147258982b359447add5027318f5b6d51963
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNA2 ARHGEF28 KCNA6	4.26e-04	188	35	3	3b8b9161f0fdcbde302ce5b4c0bc874628211109
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA6	4.26e-04	188	35	3	921a2c9212a0f2a00fd72c594d80924f27e8b9b7
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNA2 ARHGEF28 KCNA6	4.26e-04	188	35	3	c2101ded71fb16b8ddbc1f883911b1ed2a533ffc
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA6	4.33e-04	189	35	3	4e61f9cd1c06bddb47ebf98affc0f97770e26e8c
ToppCell	droplet-Heart-HEART-1m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 KCNA2 KCNA6	4.33e-04	189	35	3	a618a1ddf5097a010c6c2c7341f3a0bd46a29c02
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KCNA7 RRM2 KCND1	4.39e-04	190	35	3	3f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL4 SLC16A7 ACSS1	4.39e-04	190	35	3	b94df372bc08de11585b2467dba8c8fffff5cd92
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EEF2 SLC16A7 ACSS1	4.46e-04	191	35	3	f631749ef1f2270133664cf5eb4cf545a8482bd3
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-T_reg\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	NLGN3 KCNA2 RRM2	4.53e-04	192	35	3	94e11f68767a899cbcc6984f9398877c1e464abc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL4 SLC16A7 ACSS1	4.53e-04	192	35	3	562df5e87038c500dd3a003fe5374cb31946b145
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNA7 RRM2 KCND1	4.53e-04	192	35	3	c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSL4 SLC16A7 ACSS1	4.60e-04	193	35	3	fa8bcf2a5ab7b08fae98a1466a936995142b4309
ToppCell	facs-Thymus-nan-3m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EEF2 KCNA3 SLC16A1	4.67e-04	194	35	3	f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCell	facs-Thymus-nan-3m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EEF2 KCNA3 SLC16A1	4.67e-04	194	35	3	66c056232ac216780acf4cc8ea325bd8ed1909c9
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 POTEI FAT3	4.67e-04	194	35	3	2dcc3b99dbedaf8a6916891c85091ddb79d7ee31
ToppCell	facs-Thymus-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EEF2 KCNA3 SLC16A1	4.67e-04	194	35	3	cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_2\|COVID-19_Severe / Disease condition and Cell class	EEF2 EIF3F MAP3K3	4.67e-04	194	35	3	9a9dd34c2e1da1c67c3d9ba99b329966cb9f41d1
ToppCell	Primary_Visual_cortex_(V1C)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EEF2 KCNA2 KCNA6	4.74e-04	195	35	3	24dbb125565facd2de42d848471d4867c81acf80
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL4 SLC16A7 ACSS1	4.74e-04	195	35	3	3123e02d2894c83962ba402085b5e6422ebf8c73
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC16 ARHGEF28 FAT3	4.74e-04	195	35	3	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC16 ARHGEF28 FAT3	4.74e-04	195	35	3	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	(00)_Basal-(0)_Reference\|(00)_Basal / shred by cell type by condition	EEF2 SLC16A7 POTEF	4.81e-04	196	35	3	ba03530a20d7b29902721fd50df8d860557ddefa
ToppCell	(07)_Ionocytes-(0)_Reference\|(07)_Ionocytes / shred by cell type by condition	EEF2 SLC16A7 POTEF	4.81e-04	196	35	3	4ac33e7d11b8b0fff6ee2e9dacad49c21d63b818
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL4 SLC16A7 ACSS1	4.81e-04	196	35	3	1bfc3c85ce9501f52a912e53cbded7de74572b9d
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL4 SLC16A7 ACSS1	4.81e-04	196	35	3	e02301642243df483fd066d978317c113c04692b
ToppCell	(08)_Brush+PNEC-(0)_Reference\|(08)_Brush+PNEC / shred by cell type by condition	EEF2 SLC16A7 POTEF	4.88e-04	197	35	3	d500bfed2a76f7300f2f17b60962c18a40efd084
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF217 KCND1 SLC16A14	4.88e-04	197	35	3	31c8d6e565bbdc37843ce871fe91845b0cc18a9f
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	EEF2 EIF3F KCNA3	4.88e-04	197	35	3	78122e1fb80e0ac3084dd4f7c551996330a701df
ToppCell	(04)_Interm._basal>secr.-(0)_Reference\|(04)_Interm._basal>secr. / shred by cell type by condition	EEF2 SLC16A7 POTEF	4.88e-04	197	35	3	452462b372c66e7487de7b9140717954e1d05263
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL4 SLC16A7 ACSS1	4.95e-04	198	35	3	688b0eb5534dde40b8630ab8a3252c816711e02e
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SRF MUC16 FAT3	4.95e-04	198	35	3	dd0465b45b02cb8edf0914d19afb52fcaaeb012c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL4 SLC16A7 ACSS1	4.95e-04	198	35	3	4448d13511485a44fe7b549e4b8b6ad7637db624
ToppCell	severe-Treg\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	EEF2 EIF3F SLC16A1	4.95e-04	198	35	3	377980b9f7d02818e1d145e6884604f8bfacc4f2
ToppCell	10x5'-GI_large-bowel-Lymphocytic_B\|GI_large-bowel / Manually curated celltypes from each tissue	EEF2 EIF3F RRM2	4.95e-04	198	35	3	4fac7cdc93dc2037bae41f350b332c30b79c13fb
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF250 KCNA5 FAT3	4.95e-04	198	35	3	cbb63b255bdc92a557c5db1f08f7766ed9346607
ToppCell	(5)_Epi_suprabasal\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ACSL4 EEF2 SLC16A1	5.03e-04	199	35	3	e1d0fd71b2f3925d02638413f2155db009f103d9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EEF2 SLC16A7 ACSS1	5.03e-04	199	35	3	41f3f5df41a142240947d9a57a6a282cba0c7aaa
ToppCell	Sepsis-Bac-SEP-Lymphocyte-T/NK-dn_T\|Bac-SEP / Disease, condition lineage and cell class	KCNA3 SLC16A14 ACSS1	5.03e-04	199	35	3	4150a479b80596accf679b37aa9b0ac15cc132b2
ToppCell	LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells\|LPS_only / Treatment groups by lineage, cell group, cell type	EEF2 EIF3F KCNA3	5.03e-04	199	35	3	bd7f03bef4660c347da5f16db34d91d563908448
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	STOX2 ZNF217 ACSS1	5.10e-04	200	35	3	ef222dc4a205d670172dae74990bdb952ac92e5b
ToppCell	(5)_Epithelial_cells-(5)_Epi_suprabasal\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ACSL4 EEF2 SLC16A1	5.10e-04	200	35	3	92382ca82da3e435ccbee1c73261d55164d54779
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 STOX2 ARHGEF28	5.10e-04	200	35	3	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	STOX2 ZNF217 ACSS1	5.10e-04	200	35	3	98a994692440cb4f505b050276f0c8022c814a21
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Macroglial\|5w / Sample Type, Dataset, Time_group, and Cell type.	EEF2 EIF3F SLC16A1	5.10e-04	200	35	3	b09cc353461f2d6b943ecc24db611679378bad2b
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 STOX2 ARHGEF28	5.10e-04	200	35	3	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Sepsis-ICU-NoSEP\|Sepsis / Disease, condition lineage and cell class	EEF2 EIF3F RRM2	5.10e-04	200	35	3	173b74bd83c5018035ec73f33896d4058a2fff87
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital\|World / Primary Cells by Cluster	EEF2 EIF3F FAT3	5.10e-04	200	35	3	6bbe8e1f3e91678f1bfb14945365c1578a59a604
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19\|World / Primary Cells by Cluster	EEF2 EIF3F FAT3	5.10e-04	200	35	3	c831d9e0a7178e3634da45548f91fa9e8dc6557c
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 ARHGEF28 SLC16A14	5.10e-04	200	35	3	85c0f038bcfb42669dca2b80273b0f8a1421405e
Drug	pyraclofos	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	4.97e-18	106	35	11	CID000093460
Drug	diazoxide	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	2.57e-14	227	35	11	CID000003019
Drug	tetraethylammonium	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1	1.73e-12	236	35	10	CID000005413
Drug	clofilium	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCND1 KCND3	1.79e-11	74	35	7	CID000002798
Drug	verapamil	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.07e-10	490	35	11	CID000002520
Drug	digitoxigenine	EEF2 KCNA2 KCNA3 KCNA5 KCNA6 KCNA10	1.44e-10	51	35	6	CID000008932
Drug	4-AP	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3	1.46e-10	258	35	9	CID000001727
Drug	E 4031	KCNA2 KCNA3 KCNA5 KCNA6 KCND1 KCND3	2.06e-10	54	35	6	CID000003184
Drug	quindine	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCND1 KCND3	1.21e-09	219	35	8	CID000001065
Drug	AC1NPPZW	ACSL4 KCNA2 KCNA3 KCNA5 KCNA6 KCND3	1.08e-08	103	35	6	CID005183170
Drug	potassium	SRF KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNG3 KCNA10 KCND1 KCND3 KCNG1 KCNG4	1.73e-08	1008	35	12	CID000000813
Drug	CID10948590	KCNA2 KCNA5 KCNA6	6.63e-08	6	35	3	CID010948590
Drug	flecainide	KCNA2 KCNA5 KCNA6 KCND1 KCND3	7.71e-08	71	35	5	CID000003355
Drug	AC1Q646P	KCNA2 KCNA3 KCNA5 KCNA6	7.96e-07	47	35	4	CID000005673
Drug	Psora-4	KCNA2 KCNA5 KCNA7	9.42e-07	13	35	3	CID006603977
Drug	tetrapentylammonium	KCNA2 KCNA5 KCNA6	2.23e-06	17	35	3	CID000017248
Drug	sotalol	KCNA2 KCNA3 KCNA5 KCNA6	4.72e-06	73	35	4	CID000005253
Drug	AC1L1B9H	KCNA2 KCNA3 KCNA5 KCNA6	6.16e-06	78	35	4	CID000001341
Drug	AC1Q1NVI	KCNA2 KCNA3	6.88e-06	3	35	2	CID006439529
Drug	dextromoramide	KCNG1 BOLL	6.88e-06	3	35	2	CID000009648
Drug	2-cyano-3-phenylacrylic acid	SLC16A1 SLC16A7 SLC16A14	7.48e-06	25	35	3	CID000070534
Drug	chromanol 293B	KCNA5 KCND1 KCND3	1.76e-05	33	35	3	CID000121846
Drug	alpha-cyano-4-hydroxycinnamate	SLC16A1 SLC16A7 SLC16A14	1.76e-05	33	35	3	CID000002102
Drug	4-Aminopyridine	KCNA5 KCNA10 KCND3	1.76e-05	33	35	3	ctd:D015761
Drug	AC1MJ1SO	SLC16A1 SLC16A7 SLC16A14	1.76e-05	33	35	3	CID003084042
Drug	acetazolamide	KCNA2 KCNA3 KCNA5 KCNA6	2.16e-05	107	35	4	CID000001986
Drug	5,8-diethoxypsoralen	KCNA2 KCNA3	2.29e-05	5	35	2	CID000656729
Drug	3,4-diaminopyridine	KCNA3 KCNA5 KCNA6	2.71e-05	38	35	3	CID000005918
Drug	AC1L1IS7	EEF2 KCNA5 KCND3	4.52e-05	45	35	3	CID000004711
Drug	NSC122429	KCNA3 KCNA5	6.39e-05	8	35	2	CID000275537
Drug	barium	KCNA3 KCNA5 KCNA6 KCNA10	7.67e-05	148	35	4	CID000104810
Drug	LY97241	KCNA2 KCNA5	8.21e-05	9	35	2	CID000175064
Drug	methyl nicotinate	ACSL4 RRM2	1.03e-04	10	35	2	CID000007151
Drug	amiodarone	KCNA2 KCNA3 KCNA5 KCND3	1.04e-04	160	35	4	CID000002156
Drug	A19490	SLC16A1 SLC16A7 SLC16A14	1.18e-04	62	35	3	CID000000322
Drug	3-hydroxy-3-methylglutaric acid	KCNA2 KCNA5 ACSS1	1.24e-04	63	35	3	CID000001662
Drug	AC1L1N5A	KCNA5 BOLL	1.77e-04	13	35	2	CID000006717
Drug	AC1L974N	KCNA2 KCNA3 KCNG1	1.85e-04	72	35	3	CID000439321
Drug	CID6426996	KCNA2 KCNA3	2.07e-04	14	35	2	CID006426996
Drug	Pyruvic acid	SLC16A1 SLC16A7	2.07e-04	14	35	2	DB00119
Drug	Zalcitabine [7481-89-2]; Up 200; 19uM; HL60; HT_HG-U133A	KCND1 KCND3 KCNG1 MAP3K3	2.22e-04	195	35	4	2932_UP
Drug	Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; HL60; HG-U133A	ZNF250 ACSL4 ZNF217 SLC16A7	2.26e-04	196	35	4	1423_DN
Drug	1,N6-ethenoadenine	KCNA2 KCNA5 KCNA6	2.34e-04	78	35	3	CID000104994
Drug	Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; HL60; HT_HG-U133A	ZNF250 KCNG1 SPSB3 MAP3K3	2.35e-04	198	35	4	2714_DN
Drug	PF-01378883-00 [351320-41-7]; Down 200; 10uM; MCF7; HT_HG-U133A	ACSL4 KCNA2 ARHGEF28 KCNA5	2.35e-04	198	35	4	6363_DN
Drug	butamben	KCND1 KCND3	2.38e-04	15	35	2	CID000002482
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A	SRF KCNA5 KCND3 KCNG1	2.40e-04	199	35	4	4775_UP
Drug	sulfinpyrazone	SLC16A1 SLC16A7 SLC16A14	3.23e-04	87	35	3	CID000005342
Drug	sodium ferulate	SLC16A1 SLC16A7 SLC16A14	3.34e-04	88	35	3	CID000000709
Drug	doyle	KCNA2 KCNA3 KCNA6	3.34e-04	88	35	3	CID000002245
Drug	benzoate	SLC16A1 SLC16A7 SLC16A14 ACSS1	3.57e-04	221	35	4	CID000000242
Drug	aluminum citrate	SLC16A1 SLC16A7	4.29e-04	20	35	2	CID000091599
Disease	epilepsy (implicated_via_orthology)	KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10	2.54e-08	163	33	6	DOID:1826 (implicated_via_orthology)
Disease	lymphangioleiomyomatosis (is_marker_for)	SRF SLC16A1	7.95e-05	12	33	2	DOID:3319 (is_marker_for)
Disease	Colorectal Carcinoma	ACSL4 ZNF217 KCNA10 RRM2 KCND3 BOLL	1.14e-04	702	33	6	C0009402
Disease	cleft lip	MUC16 ARHGEF28 KCNA5 KCNG4	2.76e-04	284	33	4	EFO_0003959
Disease	electrocardiography	KCNA2 KCNA3 KCNA7 KCND3 POTEF	2.87e-04	530	33	5	EFO_0004327
Disease	colorectal adenoma	ZNF217 FAT3	6.27e-04	33	33	2	EFO_0005406
Disease	metachronous colorectal adenoma	KCNA5 FAT3	1.17e-03	45	33	2	EFO_0803377
Disease	ocular hypertension, response to triamcinolone acetonide	ZNF217 SPSB3	1.38e-03	49	33	2	EFO_0006954, EFO_1001069
Disease	mucocutaneous lymph node syndrome	SLC16A7 OR13C4	3.28e-03	76	33	2	EFO_0004246
Disease	visceral adipose tissue measurement, body mass index	KCND3 KCNG4	4.28e-03	87	33	2	EFO_0004340, EFO_0004765

Protein segments in the cluster

Peptide	Gene	Start	Entry
DMAIVMYTSGSTGRP	ACSL4	271	O60488
MLYTSGSTGMPKGIV	ACSS1	291	Q9NUB1
IMPAAGTMYLTTSTG	BOLL	121	Q8N9W6
MTTVGYGDMYPITVP	KCNG3	371	Q8TAE7
PVTMGSGSVTYVDNM	ARHGEF28	81	Q8N1W1
ISSIMLAVMYGGGPI	SLC16A1	61	P53985
PYSEVTTLMGMGPGN	MUC16	5306	Q8WXI7
TSPMGITFAMGDTSV	MUC16	5746	Q8WXI7
PMGTTYTMGETSVSI	MUC16	8381	Q8WXI7
NTVLSGGTTMYPGMA	POTEF	996	A5A3E0
TEGLVSMFYGVVTPM	OR13C4	276	Q8NGS5
SMTTVGYGDMVPTTI	KCNA2	371	P16389
TIVTMTTLGYGDMVP	KCND1	366	Q9NSA2
TIVTMTTLGYGDMVP	KCND3	361	Q9UK17
MTTVGYGDMVPRSVP	KCNG4	416	Q8TDN1
TMTTVGYGDMHPVTI	KCNA3	441	P22001
ISSIMLAVMYAGGPV	SLC16A7	61	O60669
TMTTVGYGDMVPRST	KCNG1	421	Q9UIX4
NTVLSGGTTMYPGMA	POTEE	996	Q6S8J3
VVTMTTVGYGDMCPT	KCNA10	416	Q16322
PVMVYIHGGSYMEGT	NLGN3	201	Q9NZ94
VTMTTVGYGDMRPIT	KCNA5	476	P22460
AVVTMTTVGYGDMYP	KCNA6	416	P17658
TTVGYGDMYPMTVGG	KCNA6	421	P17658
GDMYPMTVGGKIVGS	KCNA6	426	P17658
MTTVGYGDMAPVTVG	KCNA7	356	Q96RP8
YVSTLMGVPGRTMGV	EIF3F	216	O00303
TSSYDTIIMEGMPVG	FAT3	2816	Q8TDW7
TYGEGESGPMGNIMI	EEF2	191	P13639
GTGMRSVTGTPYWMS	MAP3K3	521	Q99759
STSEYGVMSPGMMTI	RTL9	131	Q8NET4
LGSGMAYLPAVVMVG	SLC16A14	136	Q7RTX9
NTVLSGGTTMYPGMA	POTEI	996	P0CG38
TSPVYGTDMMVGIGT	SPSB3	156	Q6PJ21
TSSVPTTVGGHMMYP	SRF	396	P11831
MMETYGNVVSLGLPG	ZNF250	51	P15622
VGEYQRMGVMSSPTE	RRM2	366	P31350
GYMTSGDVSPISMSP	STOX2	51	Q9P2F5
MYMDGPEVIGSSLGS	ZNF217	16	O75362